Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global pandemic of the Coronavirus disease in late 2019 (COVID-19). Vaccine development efforts have predominantly been aimed at 'Extra-viral' Spike (S) protein as vaccine vehicles, but there are concerns regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Thura, Min, Sng, Joel Xuan En, Ang, Koon Hwee, Li, Jie, Gupta, Abhishek, Hong, Jimmy Ming, Hong, Cheng William, Zeng, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2021
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463655/
https://www.ncbi.nlm.nih.gov/pubmed/34519332
http://dx.doi.org/10.1042/BSR20211491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463655/
https://www.ncbi.nlm.nih.gov/pubmed/34519332
http://dx.doi.org/10.1042/BSR20211491

Ejemplares similares